SoftOx Solutions AS Logo

SoftOx Solutions AS

SOFTX | OL

Overview

Corporate Details

ISIN(s):
NO0010811961 (+2 more)
LEI:
549300AETMWJS91G4A50
Country:
Norway
Address:
Martin Linges vei 25, 1364 Fornebu
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SoftOx Solutions AS is a clinical-stage pharmaceutical company developing a patented, non-toxic antimicrobial technology to address significant global health threats. The company's platform stabilizes a naturally occurring molecule (hypochlorous acid) to create highly effective solutions against a broad spectrum of pathogens, including bacteria, viruses, fungi, and biofilms. A key advantage of this technology is its mechanism of action, which does not contribute to the development of antimicrobial resistance (AMR). The company's primary focus includes an inhalation solution for airway infections, as well as products for advanced wound care and disinfection. SoftOx develops its technology in collaboration with leading scientific and clinical research institutions.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for SoftOx Solutions AS. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 125.5 KB
2025-08-26 14:35
Related Party Transaction
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 131.5 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification - Attachment: Skjema for meld…
Norwegian 125.5 KB
2025-08-26 14:35
Director's Dealing
SoftOx Solutions AS: Primary Insider Notification
English 2.1 KB
2025-08-18 10:36
Share Issue/Capital Change
SoftOx Solutions AS: New Share Capital
English 1.6 KB
2025-08-14 22:02
Share Issue/Capital Change
SoftOx Solutions AS: Private Placement resolved
English 3.3 KB
2025-08-14 16:28
Capital/Financing Update
SoftOx Solutions AS: Softox Solutions secures committed financing facility
English 3.8 KB
2025-06-27 14:51
Board/Management Information
SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board …
English 2.1 KB
2025-06-27 11:08
Post-Annual General Meeting Information
SoftOx Solutions AS: Minutes from the General Meeting - Attachment: SoftOx Solu…
English 497.1 KB
2025-06-27 11:08
Post-Annual General Meeting Information
SoftOx Solutions AS: Minutes from the General Meeting
English 352 bytes
2025-06-27 08:00
Quarterly Report
SoftOx Solutions AS: First Quarter Report 2025 - Attachment: SoftOx Solution_Q1…
English 911.0 KB
2025-06-27 08:00
Report Publication Announcement
SoftOx Solutions AS: First Quarter Report 2025
English 334 bytes
2025-06-13 08:02
Pre-Annual General Meeting Information
SoftOx Solutions AS: Notice of Annual General Assembly - Attachment: Call Gener…
English 2.8 MB
2025-06-13 08:02
Pre-Annual General Meeting Information
SoftOx Solutions AS: Notice of Annual General Assembly
English 1.4 KB
2025-06-12 15:08
Report Publication Announcement
Financial calendar
English 689 bytes

Automate Your Workflow. Get a real-time feed of all SoftOx Solutions AS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SoftOx Solutions AS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celon Pharma S.A. Logo
An integrated biopharma company developing drugs for neurology and cancer, from R&D to market.
Poland CLN
Chemical Works of Gedeon Richter Plc Logo
Develops and markets drugs for women's health, CNS, and cardiovascular conditions worldwide.
Hungary RICHT
Chiome Bioscience Inc. Logo Japan 4583
Chordia Therapeutics,Inc Logo Japan 190A
CHUGAI PHARMACEUTICAL CO., LTD. Logo Japan 4519
CHUKYOIYAKUHIN CO.,LTD. Logo Japan 4558
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS